Dr. Wendy Rose, director of the Jefferson Center for Autism and Neurodiversity Health, said: “It’s quiet. All our vaccinators are familiar with this population. We provide accommodation for those in need.”
There are only two chairs in the waiting room, and the staff have irritating spinners, earphones and sunglasses on hand.
The clinic carried out about 50 Johnson & Johnson vaccinations in more than six hours.
The providers in charge of this service say that this slowdown is what their IDD patients (people with intellectual or developmental disabilities) need.
Ross said: “Not everyone can tolerate a large number of people and lines. I think the people we serve are really at risk of dying from COVID.”
Rose and her team studied more than 64 million COVID-19 cases and found that IDD patients are almost six times more likely to die from the virus, and the latter is the second highest risk factor after age.
Stanley Jaskiewicz said: “Many of the people we know don’t really know how to protect themselves, or they can’t really tolerate this. I don’t like to tolerate this.” Clinic. “He doesn’t fit into any category. We don’t know when and where.”
Batisha Andrews is Jefferson’s patient, as is her brother Shawn.
They both expressed their gratitude to this clinic, and it was just an injection.
She said: “I am finally able to get the vaccination and I am very happy.”
After Jefferson’s research, 11 states, including Pennsylvania, changed the scope of their vaccines to include IDD patients.
Copyright ©2021 WPVI-TV. all rights reserved.